• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于用报告基因和治疗性转基因武装溶瘤腺病毒Ad5-Δ24-RGD的L3-23K和L5-纤维区域的比较

Comparison of the L3-23K and L5-Fiber Regions for Arming the Oncolytic Adenovirus Ad5-Delta-24-RGD with Reporter and Therapeutic Transgenes.

作者信息

Stepanenko Aleksei A, Sosnovtseva Anastasiia O, Valikhov Marat P, Vasiukova Anastasiia A, Abramova Olga V, Lipatova Anastasiia V, Yusubalieva Gaukhar M, Chekhonin Vladimir P

机构信息

Department of Fundamental and Applied Neurobiology, V. P. Serbsky National Medical Research Center of Psychiatry and Narcology, Ministry of Health of the Russian Federation, 119034 Moscow, Russia.

Department of Medical Nanobiotechnology, Institute of Translational Medicine, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, 117997 Moscow, Russia.

出版信息

Int J Mol Sci. 2025 Apr 14;26(8):3700. doi: 10.3390/ijms26083700.

DOI:10.3390/ijms26083700
PMID:40332328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12027834/
Abstract

The insertion of a transgene downstream of the L3-23K or L5-Fiber region was reported as a vital strategy for arming E3 non-deleted oncolytic adenoviruses. However, depending on the percentage of codons with G/C at the third base position (GC3%) and the type of splicing acceptor, an insert downstream of the L5-Fiber region may substantially affect virus fitness. Since the insertion of transgenes downstream of the L3-23K and L5-Fiber regions has never been compared in terms of their expression levels and impact on virus fitness, we assessed the total virus yield, cytolytic efficacy, and plaque size of Ad5-delta-24-RGD (Ad5Δ24RGD) armed with , , the suppressor of RNA silencing , soluble wild-type human/mouse and high-affinity human programmed cell death receptor-1 (PD-1/) ectodomains, and soluble human hyaluronidase PH20/. The insertion of transgenes downstream of the L3-23K region ensures their production at considerably higher levels. However, the insertion of transgenes downstream of either region differentially and unpredictably affects the oncolytic potency of Ad5Δ24RGD, which cannot be explained by GC3% or expression level alone. Surprisingly, the expression of the human and mouse PD-1 ectodomains with 83.1% and 70.1% GC3%, respectively, does not affect cytolytic efficacy but increases the plaque size in a cell line-dependent manner.

摘要

据报道,将转基因插入L3 - 23K或L5 - 纤维区域下游是武装E3未缺失的溶瘤腺病毒的关键策略。然而,根据第三碱基位置具有G/C的密码子百分比(GC3%)和剪接受体的类型,L5 - 纤维区域下游的插入可能会显著影响病毒适应性。由于从未在表达水平和对病毒适应性的影响方面对L3 - 23K和L5 - 纤维区域下游的转基因插入进行比较,我们评估了携带RNA沉默抑制因子、可溶性野生型人/小鼠和高亲和力人程序性细胞死亡受体-1(PD - 1/)胞外域以及可溶性人透明质酸酶PH20/的Ad5 - delta - 24 - RGD(Ad5Δ24RGD)的总病毒产量、细胞溶解效力和噬斑大小。在L3 - 23K区域下游插入转基因可确保其以相当高的水平产生。然而,在任一区域下游插入转基因会以不同且不可预测的方式影响Ad5Δ24RGD的溶瘤效力,这不能仅由GC3%或表达水平来解释。令人惊讶的是,人源和小鼠源PD - 1胞外域的表达,其GC3%分别为83.1%和70.1%,并不影响细胞溶解效力,但会以细胞系依赖的方式增加噬斑大小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d5/12027834/3c88de7b87e8/ijms-26-03700-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d5/12027834/8f1e012e7eb3/ijms-26-03700-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d5/12027834/8ce2a96bf15c/ijms-26-03700-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d5/12027834/4b9206f5d9bb/ijms-26-03700-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d5/12027834/3c88de7b87e8/ijms-26-03700-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d5/12027834/8f1e012e7eb3/ijms-26-03700-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d5/12027834/8ce2a96bf15c/ijms-26-03700-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d5/12027834/4b9206f5d9bb/ijms-26-03700-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d5/12027834/3c88de7b87e8/ijms-26-03700-g004.jpg

相似文献

1
Comparison of the L3-23K and L5-Fiber Regions for Arming the Oncolytic Adenovirus Ad5-Delta-24-RGD with Reporter and Therapeutic Transgenes.用于用报告基因和治疗性转基因武装溶瘤腺病毒Ad5-Δ24-RGD的L3-23K和L5-纤维区域的比较
Int J Mol Sci. 2025 Apr 14;26(8):3700. doi: 10.3390/ijms26083700.
2
Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression.比较E3区和L3区用于武装溶瘤腺病毒以实现高水平肿瘤特异性转基因表达的情况。
Cancer Gene Ther. 2008 Jan;15(1):9-17. doi: 10.1038/sj.cgt.7701093. Epub 2007 Sep 14.
3
Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness.武装溶瘤腺病毒:插入位点和剪接受体对转基因表达和病毒适应性的影响。
Int J Mol Sci. 2020 Jul 21;21(14):5158. doi: 10.3390/ijms21145158.
4
Adenovirus-Neutralizing and Infection-Promoting Activities Measured in Serum of Human Brain Cancer Patients Treated with Oncolytic Adenovirus Ad5-∆24.RGD.在接受溶瘤腺病毒Ad5-∆24.RGD治疗的人脑癌患者血清中检测到的腺病毒中和及感染促进活性。
Int J Mol Sci. 2025 Jan 20;26(2):854. doi: 10.3390/ijms26020854.
5
Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.删除E3-6.7K/gp19K区域可降低野生型腺病毒在叙利亚仓鼠允许性肿瘤模型中的持久性。
Cancer Gene Ther. 2009 Sep;16(9):703-12. doi: 10.1038/cgt.2009.12. Epub 2009 Feb 20.
6
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.整合素靶向溶瘤腺病毒 Ad5-D24-RGD 和 Ad5-RGD-D24-GMCSF 治疗晚期化疗耐药实体瘤患者。
Int J Cancer. 2012 Apr 15;130(8):1937-47. doi: 10.1002/ijc.26216. Epub 2011 Aug 8.
7
Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes.开发一种通用的溶瘤病毒平台,用于治疗性转基因在肿瘤内局部表达。
PLoS One. 2017 May 18;12(5):e0177810. doi: 10.1371/journal.pone.0177810. eCollection 2017.
8
Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.纤维修饰、中期因子启动子调控的溶瘤腺病毒增强人恶性间皮瘤的抗肿瘤疗效。
Cancer Sci. 2013 Nov;104(11):1433-9. doi: 10.1111/cas.12267. Epub 2013 Sep 23.
9
Replication-dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor site.通过剪接至异源剪接受体位点的可变剪接,实现来自条件性复制腺病毒的依赖复制的转基因表达。
J Gene Med. 2005 Aug;7(8):1053-62. doi: 10.1002/jgm.754.
10
The genome position of a therapeutic transgene strongly influences the level of expression in an armed oncolytic human adenovirus vector.治疗性转基因在基因组中的位置会强烈影响武装溶瘤型人腺病毒载体的表达水平。
Virology. 2021 Sep;561:87-97. doi: 10.1016/j.virol.2021.06.005. Epub 2021 Jun 18.

引用本文的文献

1
Oncolytic Therapies for Glioblastoma: Advances, Challenges, and Future Perspectives.胶质母细胞瘤的溶瘤疗法:进展、挑战与未来展望
Cancers (Basel). 2025 Aug 1;17(15):2550. doi: 10.3390/cancers17152550.

本文引用的文献

1
Codon-optimization in gene therapy: promises, prospects and challenges.基因治疗中的密码子优化:前景、展望与挑战。
Front Bioeng Biotechnol. 2024 Mar 28;12:1371596. doi: 10.3389/fbioe.2024.1371596. eCollection 2024.
2
Specific codons control cellular resources and fitness.特定的密码子控制着细胞的资源和适应性。
Sci Adv. 2024 Feb 23;10(8):eadk3485. doi: 10.1126/sciadv.adk3485. Epub 2024 Feb 21.
3
Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches.免疫检查点抑制剂:基于小分子和肽的方法。
J Pers Med. 2024 Jan 4;14(1):68. doi: 10.3390/jpm14010068.
4
The Effects of Codon Usage on Protein Structure and Folding.密码子使用对蛋白质结构和折叠的影响。
Annu Rev Biophys. 2024 Jul;53(1):87-108. doi: 10.1146/annurev-biophys-030722-020555. Epub 2024 Jun 28.
5
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.溶瘤病毒 DNX-2401 联合派姆单抗治疗复发性胶质母细胞瘤:一项 1/2 期试验。
Nat Med. 2023 Jun;29(6):1370-1378. doi: 10.1038/s41591-023-02347-y. Epub 2023 May 15.
6
Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment.携带共刺激分子的溶瘤腺病毒用于癌症治疗
Cancers (Basel). 2023 Mar 23;15(7):1947. doi: 10.3390/cancers15071947.
7
A Renaissance for Oncolytic Adenoviruses?溶瘤腺病毒的复兴?
Viruses. 2023 Jan 26;15(2):358. doi: 10.3390/v15020358.
8
Global Transcriptome Analyses of Cellular and Viral mRNAs during HAdV-C5 Infection Highlight New Aspects of Viral mRNA Biogenesis and Cytoplasmic Viral mRNA Accumulations.HAdV-C5 感染过程中细胞和病毒 mRNA 的全球转录组分析突显了病毒 mRNA 生成和细胞质病毒 mRNA 积累的新方面。
Viruses. 2022 Nov 1;14(11):2428. doi: 10.3390/v14112428.
9
Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses.锁定并装载:工程化和武装溶瘤腺病毒以增强抗肿瘤免疫反应。
Expert Opin Biol Ther. 2022 Nov;22(11):1359-1378. doi: 10.1080/14712598.2022.2139601. Epub 2022 Nov 9.
10
Novel viral splicing events and open reading frames revealed by long-read direct RNA sequencing of adenovirus transcripts.长读直接 RNA 测序揭示腺病毒转录本中的新型病毒剪接事件和开放阅读框。
PLoS Pathog. 2022 Sep 12;18(9):e1010797. doi: 10.1371/journal.ppat.1010797. eCollection 2022 Sep.